News from the Institute
Ellison Medical Institute and UniQuest enter exclusive license to advance novel prostate cancer therapy toward first-in-human studies
The Institute has entered into an exclusive license with UniQuest to advance QED-203, a promising new treatment for advanced and therapy-resistant prostate cancer, toward first-in-human studies
Toward a Data-Driven Future: Health Leaders Urge Federal Strategy to Cut U.S. Cancer Deaths
A unified federal approach to health data sharing, developed in partnership with states, could accelerate progress in cancer prevention, care, and research
Our Genes Change! New Study Tracks Real-Time Genetic Changes Using Blood-Based Long-Read Sequencing
Ellison Medical Institute researchers have shown that the rate of change of DNA sequence can be tracked over time, opening doors to personalized cancer prevention programs and better early cancer detection
Media Inquiries
For all press inquiries, please contact [email protected].